By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.

The Voice of People With Breast Cancer


& Resources

Precision Oncology and Breast Cancer: Considering Canada's Approach in an Evolving Landscape

The cancer treatment landscape is undergoing a seismic shift with the emergence and evolution of precision oncology approaches. With genomic profiling or testing, clinicians and patients can identify key drivers of a patient's cancerous tumour, which may better predict disease behaviour, in turn informing more precise treatment decisions. In addition to providing an expanded array of treatment options, a more targeted method can potentially reduce treatment toxicities, improve outcomes, and provide a better quality of life for patients. As decisions emerge around the regulation and implementation of both testing and treatment, it is critical they are informed by patient and physician values.

To help understand the different perspectives and values on precision oncology in breast cancer and the role of testing and data, the CBCN hosted two national virtual roundtables - one with breast cancer patients living with different types and stages of disease and one with oncologists. Precision Oncology and Breast Cancer: Considering Canada's Approach in an Evolving Landscape shares observations, key takeaways and recommendations based on insights collected from these conversations.


On Tuesday, March 8th, Dr. Brandon Sheffield, pathologist at the William Osler Health System in Brampton, shared how precision oncology tools can be used to better understand each patients’ cancer and how treatment plans can then be personalized for each patient.

Watch the on-demand video

In our Accessing Genomic Testing in Canada, we provide information on what genomic testing is, when to get it done, and what this test means to breast cancer patients so that you can discuss with your healthcare team whether accessing genomic testing is right for you. At the end of the guide, we provide various advocacy steps that breast cancer patients in Canada can take to access genomic testing.

Read now



Your path to accessing financial resources

Quick Find

Our Stories


See our calendar